Literature DB >> 35110267

High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.

Miguel Guia1, Nilgun Alpay2, António Gerardo1, Yasmin Madney3, Mohamed Abdelrahim3, Haitham Saeed3, Hadeer Harb3, Gil Gonçalves4, Bruno Cabrita5, Jaber Alqahtani6, Mohamad El-Khatib7, Manuel Gómez-Ríos8, Atefeh Fakharian9, Laura Ciobanu10, Habib Md Reazaul Karim11, Edoardo Piervincenzi12, Martin Scharffenberg13, Paschalis Steiropoulos14, William LeMaster15, Igor Barjaktarevic15, Jakob Wittenstein13, Montserrat Diaz-Abad16, Andreas Perren17, Antonello Nicolini18, Savino Spadaro19, Giancarlo Garuti20, Angelo Petroianni21, Antonio Esquinas22.   

Abstract

High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.

Entities:  

Year:  2021        PMID: 35110267      PMCID: PMC8975303          DOI: 10.5152/TurkThoracJ.2021.20213

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  29 in total

1.  Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study.

Authors:  Benjamin Sztrymf; Jonathan Messika; Thomas Mayot; Hugo Lenglet; Didier Dreyfuss; Jean-Damien Ricard
Journal:  J Crit Care       Date:  2011-09-29       Impact factor: 3.425

2.  A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients.

Authors:  Rachael L Parke; Shay P McGuinness; Michelle L Eccleston
Journal:  Respir Care       Date:  2011-01-21       Impact factor: 2.258

Review 3.  High-Flow Nasal Cannula Oxygen Therapy Devices.

Authors:  Masaji Nishimura
Journal:  Respir Care       Date:  2019-06       Impact factor: 2.258

4.  High-Flow Nasal Cannula Therapy for Acute Hypoxemic Respiratory Failure in Adults: A Retrospective Analysis.

Authors:  Woo Hyun Cho; Hye Ju Yeo; Seong Hoon Yoon; SeungEun Lee; Doo SooJeon; Yun Seong Kim; Ki Uk Kim; Kwangha Lee; Hye Kyung Park; Min Ki Lee
Journal:  Intern Med       Date:  2015-09-15       Impact factor: 1.271

5.  Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study.

Authors:  Jonathan Messika; Karim Ben Ahmed; Stéphane Gaudry; Romain Miguel-Montanes; Cédric Rafat; Benjamin Sztrymf; Didier Dreyfuss; Jean-Damien Ricard
Journal:  Respir Care       Date:  2014-11-04       Impact factor: 2.258

6.  High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v.

Authors:  Jordi Rello; Marcos Pérez; Oriol Roca; Garyphallia Poulakou; Jéssica Souto; César Laborda; Joan Balcells; Joaquim Serra; Joan Ramon Masclans
Journal:  J Crit Care       Date:  2012-07-02       Impact factor: 3.425

7.  High-flow nasal cannula therapy in do-not-intubate patients with hypoxemic respiratory distress.

Authors:  Steve G Peters; Steven R Holets; Peter C Gay
Journal:  Respir Care       Date:  2013-04       Impact factor: 2.258

Review 8.  Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device.

Authors:  Eleni Ischaki; Ioannis Pantazopoulos; Spyros Zakynthinos
Journal:  Eur Respir Rev       Date:  2017-08-09

9.  Randomized Controlled Trial of Humidified High-Flow Nasal Oxygen for Acute Respiratory Distress in the Emergency Department: The HOT-ER Study.

Authors:  Peter G Jones; Sinan Kamona; Owen Doran; Frann Sawtell; Margaret Wilsher
Journal:  Respir Care       Date:  2015-11-17       Impact factor: 2.258

10.  The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial.

Authors:  Virginie Lemiale; Djamel Mokart; Julien Mayaux; Jérôme Lambert; Antoine Rabbat; Alexandre Demoule; Elie Azoulay
Journal:  Crit Care       Date:  2015-11-02       Impact factor: 9.097

View more
  2 in total

1.  Letter to the Editor: "Feasibility of non- invasive respiratory drive and breathing pattern evaluation using CPAP in COVID-19 patients".

Authors:  Antonio M Esquinas; Pradipta Bhakta; Brian O'Brien; Mohanchandra Mandal
Journal:  J Crit Care       Date:  2022-05-31       Impact factor: 4.298

2.  Methodological Insight to the High-Flow Nasal Cannula Oxygenation in Elderly Undergoing Endoscopic Retrograde Cholangiopancreatography.

Authors:  Salvatore Notaro; Habib Md Reazaul Karim; Antonio M Esquinas
Journal:  Dig Dis Sci       Date:  2022-04-08       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.